Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sands

Showing results (101-110 of 513) with videos related to

Pageof 52
Sort By:
Humangenetik|January 1, 1973
XXXX syndrome: case report, and a note on genetic counselling and fertilityR J Gardner, A M Veale, V E Sands, et al.
Gastroenterology|April 13, 2005
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's diseaseGary R Lichtenstein, Songkai Yan, Mohan Bala, et al.
Gastroenterology|December 3, 2014
Mark Warren Babyatsky, MD (June 29, 1959-August 25, 2014)Steven H Itzkowitz, Bruce E Sands, Thomas A Ullman, et al.
The New England Journal of Medicine|July 2, 1970
Familial syndrome of streak gonads and normal male karyotype in five phenotypic femalesE A Espiner, A M Veale, V E Sands, et al.
Inflammatory Bowel Diseases|October 11, 2007
Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel diseaseCorey A Siegel, L Campbell Levy, Todd A Mackenzie, et al.
Rhode Island Medical Journal (2013)|November 22, 2022
Lessons Learned from the Ocean State Crohn's and Colitis Area RegistryJason M Shapiro, Neal S LeLeiko, Bruce E Sands, et al.
Medicine and Health, Rhode Island|April 24, 2009
OSCCAR: Ocean State Crohn's and Colitis Area RegistryBruce E Sands, Neal LeLeiko, Samir A Shah, et al.
Infection Control and Hospital Epidemiology|November 24, 2024
Risk factors for healthcare-associated infection among patients hospitalized with COVID-19 infectionKenneth E Sands, E Jackie Blanchard, Adam Hasse, et al.
Alimentary Pharmacology & Therapeutics|April 13, 2023
Review article: Putting some muscle into sarcopenia-the pathogenesis, assessment and clinical impact of muscle loss in patients with inflammatory bowel diseaseStephanie L Gold, Maitreyi Raman, Bruce E Sands, et al.
Gastroenterology & Hepatology|November 15, 2023
Therapeutic Targets for Emerging Biologic Therapies in IBDStephen B Hanauer, Scott E Plevy, Bruce E Sands, et al.
Pageof 52

Showing results (101-110 of 513) with videos related to

Sort By:
Pageof 52
Humangenetik|January 1, 1973
XXXX syndrome: case report, and a note on genetic counselling and fertilityR J Gardner, A M Veale, V E Sands, et al.
Gastroenterology|April 13, 2005
Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's diseaseGary R Lichtenstein, Songkai Yan, Mohan Bala, et al.
Gastroenterology|December 3, 2014
Mark Warren Babyatsky, MD (June 29, 1959-August 25, 2014)Steven H Itzkowitz, Bruce E Sands, Thomas A Ullman, et al.
The New England Journal of Medicine|July 2, 1970
Familial syndrome of streak gonads and normal male karyotype in five phenotypic femalesE A Espiner, A M Veale, V E Sands, et al.
Inflammatory Bowel Diseases|October 11, 2007
Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel diseaseCorey A Siegel, L Campbell Levy, Todd A Mackenzie, et al.
Rhode Island Medical Journal (2013)|November 22, 2022
Lessons Learned from the Ocean State Crohn's and Colitis Area RegistryJason M Shapiro, Neal S LeLeiko, Bruce E Sands, et al.
Medicine and Health, Rhode Island|April 24, 2009
OSCCAR: Ocean State Crohn's and Colitis Area RegistryBruce E Sands, Neal LeLeiko, Samir A Shah, et al.
Infection Control and Hospital Epidemiology|November 24, 2024
Risk factors for healthcare-associated infection among patients hospitalized with COVID-19 infectionKenneth E Sands, E Jackie Blanchard, Adam Hasse, et al.
Alimentary Pharmacology & Therapeutics|April 13, 2023
Review article: Putting some muscle into sarcopenia-the pathogenesis, assessment and clinical impact of muscle loss in patients with inflammatory bowel diseaseStephanie L Gold, Maitreyi Raman, Bruce E Sands, et al.
Gastroenterology & Hepatology|November 15, 2023
Therapeutic Targets for Emerging Biologic Therapies in IBDStephen B Hanauer, Scott E Plevy, Bruce E Sands, et al.
Pageof 52